Differential binding of tropane-based photoaffinity ligands on the dopamine transporter

Roxanne A. Vaughan, Gregory E. Agoston, John R. Lever, Amy Hauck Newman

Research output: Contribution to journalArticle

Abstract

Benztropine and its analogs are tropane ring-containing dopamine uptake inhibitors that produce behavioral effects markedly different from cocaine and other dopamine transporter blockers. We investigated the benztropine binding site on dopamine transporters by covalently attaching a benztropine- based photoaffinity ligand, [125I]N-[n-butyl-4-(4'-azido-3'- iodophenyl)]4',4-difluoro-3α-(diphenylmethoxy)tropane ([1251]GA II 34), to the protein, followed by proteolytic and immunological peptide mapping. The maps were compared with those obtained for dopamine transporters photoaffinity labeled with a GBR 12935 analog, [125I]1-[2- (diphenylmethoxy)ethyl]-4-[2-(4-azido-3-iodophenyl)ethyl]piperazine ([125I]DEEP), and a cocaine analog, [125I]3β-(p-chlorophenyl)tropane- 2β-carboxylic acid, 4'-azido-3'-iodophenylethyl ester ([1251]RTI 82), which have been shown previously to interact with different regions of the primary sequence of the protein. [1251]GA II 34 became incorporated in a membrane-bound, 14 kDa fragment predicted to contain transmembrane domains I and 2. This is the same region of the protein that binds [1251]DEEP, whereas the binding site for [125I]RTI 82 occurs closer to the C terminal in a domain containing transmembrane helices 4-7. Thus, although benztropine and cocaine both contain tropane rings, their binding sites are distinct, suggesting that dopamine transport inhibition may occur by different mechanisms. These results support previously derived structure-activity relationships suggesting that benztropine and cocaine analogs bind to different domains on the dopamine transporter. These differing molecular interactions may lead to the distinctive behavioral profiles of these compounds in animal models of drug abuse and indicate promise for the development of benztropine-based molecules for cocaine substitution therapies.

Original languageEnglish (US)
Pages (from-to)630-636
Number of pages7
JournalJournal of Neuroscience
Volume19
Issue number2
StatePublished - Jan 15 1999

Fingerprint

Benztropine
Tropanes
Dopamine Plasma Membrane Transport Proteins
Cocaine
Ligands
Binding Sites
Dopamine Uptake Inhibitors
Proteins
Peptide Mapping
Dopamine Antagonists
Structure-Activity Relationship
Carboxylic Acids
Substance-Related Disorders
Dopamine
Esters
Animal Models
Membranes

Keywords

  • Benztropine
  • Cocaine
  • Dopamine transporter
  • Dopamine uptake
  • Immunoprecipitation
  • Photoaffinity label
  • Proteolytic peptide mapping

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. / Vaughan, Roxanne A.; Agoston, Gregory E.; Lever, John R.; Newman, Amy Hauck.

In: Journal of Neuroscience, Vol. 19, No. 2, 15.01.1999, p. 630-636.

Research output: Contribution to journalArticle

Vaughan, Roxanne A. ; Agoston, Gregory E. ; Lever, John R. ; Newman, Amy Hauck. / Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. In: Journal of Neuroscience. 1999 ; Vol. 19, No. 2. pp. 630-636.
@article{e52f85ddc85647b49a9f24a3f96ed934,
title = "Differential binding of tropane-based photoaffinity ligands on the dopamine transporter",
abstract = "Benztropine and its analogs are tropane ring-containing dopamine uptake inhibitors that produce behavioral effects markedly different from cocaine and other dopamine transporter blockers. We investigated the benztropine binding site on dopamine transporters by covalently attaching a benztropine- based photoaffinity ligand, [125I]N-[n-butyl-4-(4'-azido-3'- iodophenyl)]4',4-difluoro-3α-(diphenylmethoxy)tropane ([1251]GA II 34), to the protein, followed by proteolytic and immunological peptide mapping. The maps were compared with those obtained for dopamine transporters photoaffinity labeled with a GBR 12935 analog, [125I]1-[2- (diphenylmethoxy)ethyl]-4-[2-(4-azido-3-iodophenyl)ethyl]piperazine ([125I]DEEP), and a cocaine analog, [125I]3β-(p-chlorophenyl)tropane- 2β-carboxylic acid, 4'-azido-3'-iodophenylethyl ester ([1251]RTI 82), which have been shown previously to interact with different regions of the primary sequence of the protein. [1251]GA II 34 became incorporated in a membrane-bound, 14 kDa fragment predicted to contain transmembrane domains I and 2. This is the same region of the protein that binds [1251]DEEP, whereas the binding site for [125I]RTI 82 occurs closer to the C terminal in a domain containing transmembrane helices 4-7. Thus, although benztropine and cocaine both contain tropane rings, their binding sites are distinct, suggesting that dopamine transport inhibition may occur by different mechanisms. These results support previously derived structure-activity relationships suggesting that benztropine and cocaine analogs bind to different domains on the dopamine transporter. These differing molecular interactions may lead to the distinctive behavioral profiles of these compounds in animal models of drug abuse and indicate promise for the development of benztropine-based molecules for cocaine substitution therapies.",
keywords = "Benztropine, Cocaine, Dopamine transporter, Dopamine uptake, Immunoprecipitation, Photoaffinity label, Proteolytic peptide mapping",
author = "Vaughan, {Roxanne A.} and Agoston, {Gregory E.} and Lever, {John R.} and Newman, {Amy Hauck}",
year = "1999",
month = "1",
day = "15",
language = "English (US)",
volume = "19",
pages = "630--636",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "2",

}

TY - JOUR

T1 - Differential binding of tropane-based photoaffinity ligands on the dopamine transporter

AU - Vaughan, Roxanne A.

AU - Agoston, Gregory E.

AU - Lever, John R.

AU - Newman, Amy Hauck

PY - 1999/1/15

Y1 - 1999/1/15

N2 - Benztropine and its analogs are tropane ring-containing dopamine uptake inhibitors that produce behavioral effects markedly different from cocaine and other dopamine transporter blockers. We investigated the benztropine binding site on dopamine transporters by covalently attaching a benztropine- based photoaffinity ligand, [125I]N-[n-butyl-4-(4'-azido-3'- iodophenyl)]4',4-difluoro-3α-(diphenylmethoxy)tropane ([1251]GA II 34), to the protein, followed by proteolytic and immunological peptide mapping. The maps were compared with those obtained for dopamine transporters photoaffinity labeled with a GBR 12935 analog, [125I]1-[2- (diphenylmethoxy)ethyl]-4-[2-(4-azido-3-iodophenyl)ethyl]piperazine ([125I]DEEP), and a cocaine analog, [125I]3β-(p-chlorophenyl)tropane- 2β-carboxylic acid, 4'-azido-3'-iodophenylethyl ester ([1251]RTI 82), which have been shown previously to interact with different regions of the primary sequence of the protein. [1251]GA II 34 became incorporated in a membrane-bound, 14 kDa fragment predicted to contain transmembrane domains I and 2. This is the same region of the protein that binds [1251]DEEP, whereas the binding site for [125I]RTI 82 occurs closer to the C terminal in a domain containing transmembrane helices 4-7. Thus, although benztropine and cocaine both contain tropane rings, their binding sites are distinct, suggesting that dopamine transport inhibition may occur by different mechanisms. These results support previously derived structure-activity relationships suggesting that benztropine and cocaine analogs bind to different domains on the dopamine transporter. These differing molecular interactions may lead to the distinctive behavioral profiles of these compounds in animal models of drug abuse and indicate promise for the development of benztropine-based molecules for cocaine substitution therapies.

AB - Benztropine and its analogs are tropane ring-containing dopamine uptake inhibitors that produce behavioral effects markedly different from cocaine and other dopamine transporter blockers. We investigated the benztropine binding site on dopamine transporters by covalently attaching a benztropine- based photoaffinity ligand, [125I]N-[n-butyl-4-(4'-azido-3'- iodophenyl)]4',4-difluoro-3α-(diphenylmethoxy)tropane ([1251]GA II 34), to the protein, followed by proteolytic and immunological peptide mapping. The maps were compared with those obtained for dopamine transporters photoaffinity labeled with a GBR 12935 analog, [125I]1-[2- (diphenylmethoxy)ethyl]-4-[2-(4-azido-3-iodophenyl)ethyl]piperazine ([125I]DEEP), and a cocaine analog, [125I]3β-(p-chlorophenyl)tropane- 2β-carboxylic acid, 4'-azido-3'-iodophenylethyl ester ([1251]RTI 82), which have been shown previously to interact with different regions of the primary sequence of the protein. [1251]GA II 34 became incorporated in a membrane-bound, 14 kDa fragment predicted to contain transmembrane domains I and 2. This is the same region of the protein that binds [1251]DEEP, whereas the binding site for [125I]RTI 82 occurs closer to the C terminal in a domain containing transmembrane helices 4-7. Thus, although benztropine and cocaine both contain tropane rings, their binding sites are distinct, suggesting that dopamine transport inhibition may occur by different mechanisms. These results support previously derived structure-activity relationships suggesting that benztropine and cocaine analogs bind to different domains on the dopamine transporter. These differing molecular interactions may lead to the distinctive behavioral profiles of these compounds in animal models of drug abuse and indicate promise for the development of benztropine-based molecules for cocaine substitution therapies.

KW - Benztropine

KW - Cocaine

KW - Dopamine transporter

KW - Dopamine uptake

KW - Immunoprecipitation

KW - Photoaffinity label

KW - Proteolytic peptide mapping

UR - http://www.scopus.com/inward/record.url?scp=0033556371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033556371&partnerID=8YFLogxK

M3 - Article

C2 - 9880583

AN - SCOPUS:0033556371

VL - 19

SP - 630

EP - 636

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 2

ER -